This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,462.60 firm fixed-price delivery order contract is for the provision of MENQUADFI VIAL 0.5ML, a medical product. The contract has a period of performance through November 20, 2024 and was awarded on November 19, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside requirements, suggesting open competition. Through its extensive supply chain and distribution capabilities, AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Generated 2/18/25, 1:50 PM